MedPath

Effects of a Large Increase in Dietary Fats and Cholesterol on HDL Composition and Function in Healthy Subjects

Not Applicable
Completed
Conditions
Lipids
Interventions
Dietary Supplement: High fat/cholesterol diet
Dietary Supplement: Low fat/cholesterol diet
Registration Number
NCT02549144
Lead Sponsor
Azienda Ospedaliero, Universitaria Pisana
Brief Summary

In this study the investigators aimed at measuring the effect of a two-week high-fat/high-cholesterol (HFHC) normocaloric diet on HDL particles biochemical composition and HDL function compared to a two-week low-fat/low-cholesterol (LFLC) normocaloric diet.

Detailed Description

HDL particles can change their composition and function in response to a variety of pathological conditions and environmental stimuli. It has been previously shown that a western diet is able to drastically modify biochemical composition, anti-inflammatory and anti-oxidant properties of HDL in animals. In humans little is known on the role of diet on HDL function and composition.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • Subjects ≥ 18 and ≤40 years of age
  • Lean or overweight (BMI: 18 to 29,9 kg/m2)
  • Normal liver and kidney function
  • Normal thyroid function
  • Stable weight in the last 3 months
  • Read and understood the informed consent form and signed it voluntarily
Exclusion Criteria
  • Liver, heart, kidney, lung, infectious, neurological, psychiatric, endocrine, immunological or neoplastic diseases
  • Chronic use of drugs or vitamin supplements
  • Smoking
  • Pregnancy or lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
High fat/cholesterol dietHigh fat/cholesterol dietHigh-fat/high-cholesterol (HFHC) normocaloric diet for 14 days.
Low fat/cholesterol dietLow fat/cholesterol dietLow-fat/low-cholesterol (LFLC) normocaloric diet for 14 days.
Primary Outcome Measures
NameTimeMethod
Dichlorofluorescein fluorescence slope14 days
Secondary Outcome Measures
NameTimeMethod
hydroxyeicosatetraenoic acid14 days
hydroxyoctadecadienoic acid14 days

Trial Locations

Locations (1)

Azienda Ospedaliero-Universitaria Pisana

🇮🇹

Pisa, PI, Italy

© Copyright 2025. All Rights Reserved by MedPath